105 related articles for article (PubMed ID: 10826362)
1. [Better therapeutic potential for azathioprine and mercaptopurine].
Bergan S; Norge O
Lakartidningen; 2000 Apr; 97(16):1999-2000. PubMed ID: 10826362
[No Abstract] [Full Text] [Related]
2. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
3. Preventing toxicity with a gene test.
Marshall E
Science; 2003 Oct; 302(5645):588-90. PubMed ID: 14576416
[No Abstract] [Full Text] [Related]
4. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
5. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
[No Abstract] [Full Text] [Related]
6. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
Kapoor G; Sinha R; Naithani R; Chandgothia M
Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow depression after azathioprine. New discoveries on an old drug].
Löwhagen GB; Lindstedt G
Lakartidningen; 2000 Feb; 97(5):458-62. PubMed ID: 10707497
[TBL] [Abstract][Full Text] [Related]
9. The challenge of obesity in paediatric leukaemia treatment: it is not just size that matters.
Tolbert J; Kearns GL
Arch Dis Child; 2015 Jan; 100(1):101-5. PubMed ID: 25336436
[TBL] [Abstract][Full Text] [Related]
10. A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia.
Donnan JR; Ungar WJ; Mathews M; Hancock-Howard RL; Rahman P
Pediatr Blood Cancer; 2011 Aug; 57(2):231-9. PubMed ID: 21344614
[TBL] [Abstract][Full Text] [Related]
11. Serendipity-methotrexate and 6-mercaptopurine for continuation therapy for patients with acute lymphoblastic leukemia: the leukemic stem cell and beyond?
Kamen BA
J Pediatr Hematol Oncol; 2009 Jun; 31(6):383-4. PubMed ID: 19648785
[No Abstract] [Full Text] [Related]
12. Thiopurine S-methyltransferase (TPMT) gene polymorphism in Brazilian children with acute lymphoblastic leukemia: association with clinical and laboratory data.
Silva MR; de Oliveira BM; Viana MB; Murao M; Romanha AJ
Ther Drug Monit; 2008 Dec; 30(6):700-4. PubMed ID: 19057372
[TBL] [Abstract][Full Text] [Related]
13. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
15. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
16. A step toward more accurate dosing for mercaptopurine in childhood acute lymphoblastic leukemia.
Mulla H; Leary A; White P; Pandya HC
J Clin Pharmacol; 2012 Oct; 52(10):1610-3. PubMed ID: 22174432
[No Abstract] [Full Text] [Related]
17. Thiopurine biology and pharmacology.
Aarbakke J; Janka-Schaub G; Elion GB
Trends Pharmacol Sci; 1997 Jan; 18(1):3-7. PubMed ID: 9114722
[No Abstract] [Full Text] [Related]
18. Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?
Mahoney DH; Camitta BM; Devidas M
Pediatr Blood Cancer; 2006 May; 46(5):660-1. PubMed ID: 16276523
[No Abstract] [Full Text] [Related]
19. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
Cha JM; Kim HJ
Korean J Gastroenterol; 2008 May; 51(5):319-22. PubMed ID: 18516018
[No Abstract] [Full Text] [Related]
20. Biology and pharmacology of thiopurines.
Aarbakke J
Pediatr Hematol Oncol; 1995; 12(5):511-9. PubMed ID: 8519640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
